May 8, 2015 — Dr. Steven LeBoeuf speaks with The Bloomberg Advantage about the importance of accuracy in wearable technology and the increase in adoption the Company is seeing in its PerformTek license partners. Read More
- Valencell Announces Medical Advisory Board Founding Members
- Managing hypertension will change more in next 5 years than the last 100 years
- What is cumulative blood pressure and why does it matter?
- Will wearables ever accurately measure blood pressure?
- Valencell’s Cuffless, Calibration-Free Blood Pressure Monitoring Technology Selected to Present at American College of Cardiology Annual Scientific Session